FENC

13.0902.68%
CC

Christiana Cioffi

Chief Strategy Officer

Ms. Christiana Cioffi, M.B.A., serves as Chief Strategy Officer of Fennec Pharmaceuticals Inc. from October 28, 2024. She has years of collective and demonstrated excellence in strategy, leadership and culture building, inclusive proven track record of developing award-winning, disruptive strategies and launch excellence from early stage through life cycle management phases with leading biopharmaceutical companies. As a recipient of multiple industry marketing awards, Ms. Cioffi has focused primarily in oncology, rare disease and hematology therapeutic areas at companies, including Shield Therapeutics, Stemline Therapeutics, EUSA Pharma, Karyopharm Therapeutics, Servier (previously Shire/Baxalta/Baxter) and Abbott Laboratories. During her tenure in the industry, Ms. Cioffi has led commercial and marketing strategy for several oncology and rare disease brands, including Qarziba, Oncaspar Liquid, Oncaspar Lyo, Cal-PEG, Sylvant, Xpovio and Elzonris. Prior to her appointment at Fennec, she served as a strategic advisor and leadership coach at Disruptify Consulting. Ms. Cioffi is a decorated Army Veteran, a Bronze Star Recipient, with proven and outstanding leadership skills while leading soldiers in combat and two deployments during Operation Iraqi Freedom.

Positions